<p><a style="color: #231f20;" href="https://www.medicalnewstoday.com/articles/acute-leukemia-30-of-participants-achieve-remission-with-new-drug" target="_top" class="ke-link">급성 백혈병: 참가자의 30%가 신약으로 관해 달성</a></p><div class="figure-open" contenteditable="false" data-ke-type="opengraph" data-ke-align="alignCenter" data-og-type="website" data-og-title="Acute leukemia: Menin-targeting drug revumenib aids remission in trial" data-og-description="A treatment called revumenib, which inhibits the protein menin, showed promising results for individuals with acute leukemia, and aided remission in 30% of study participants." data-og-host="www.medicalnewstoday.com" data-og-source-url="https://www.medicalnewstoday.com/articles/acute-leukemia-30-of-participants-achieve-remission-with-new-drug" data-og-url="https://www.medicalnewstoday.com/articles/acute-leukemia-30-of-participants-achieve-remission-with-new-drug" data-og-image="https://scrap.kakaocdn.net/dn/hkiJf/hyR124sEnD/aKqTh6d1xUtty7uCDEKNvk/img.jpg?width=732&height=549&face=0_0_732_549,https://scrap.kakaocdn.net/dn/bqGASO/hyR13beDDO/VFkS9vb9WfiCDo5dbP9lU0/img.jpg?width=732&height=549&face=0_0_732_549,https://scrap.kakaocdn.net/dn/cLexc4/hyR16sglLK/3clk6r9YY8SDMzu3WQQNk1/img.jpg?width=732&height=549&face=0_0_732_549"><a href="https://www.medicalnewstoday.com/articles/acute-leukemia-30-of-participants-achieve-remission-with-new-drug" target="_blank" data-source-url="https://www.medicalnewstoday.com/articles/acute-leukemia-30-of-participants-achieve-remission-with-new-drug"><div class="og-image" style="background-image:url(https://scrap.kakaocdn.net/dn/hkiJf/hyR124sEnD/aKqTh6d1xUtty7uCDEKNvk/img.jpg?width=732&height=549&face=0_0_732_549,https://scrap.kakaocdn.net/dn/bqGASO/hyR13beDDO/VFkS9vb9WfiCDo5dbP9lU0/img.jpg?width=732&height=549&face=0_0_732_549,https://scrap.kakaocdn.net/dn/cLexc4/hyR16sglLK/3clk6r9YY8SDMzu3WQQNk1/img.jpg?width=732&height=549&face=0_0_732_549)"></div><div class="og-text"><p class="og-title">Acute leukemia: Menin-targeting drug revumenib aids remission in trial</p><p class="og-desc">A treatment called revumenib, which inhibits the protein menin, showed promising results for individuals with acute leukemia, and aided remission in 30% of study participants.</p><p class="og-host">www.medicalnewstoday.com</p></div></a></div><p> </p>
<!-- -->
